ATTORNEY ADVERTISEMENT. Samuel L. Eilers, Esq. (CA SBN 289222), 3099 Driscoll Drive, San Diego, CA 92117
Advertising by a legal marketing service. No attorney-client relationship is formed.
Ozempic / GLP-1 Lawsuit
GLP-1 drugs including Ozempic, Wegovy, and Mounjaro face claims for gastroparesis, intestinal obstruction, and vision issues.
Reported case value ranges (not guaranteed): Varies by injury
Results vary. Past results do not guarantee future outcomes. No compensation is guaranteed.
Symptoms & Injuries
- Gastroparesis
- Intestinal blockage
- Persistent vomiting
- NAION / vision loss
Eligibility Criteria
- • Used Ozempic, Wegovy, Mounjaro, or similar
- • Hospitalization or severe GI injury
- • Injury after starting medication
Lawsuit Updates
2024
MDL formation under review
Federal courts evaluating consolidation of GLP-1 injury claims.
MDL Information
- Court
- Pending consolidation
- Docket
- Emerging MDL
- Filed
- 2024
- Overview
- Growing litigation over GLP-1 adverse events.
FAQ
Individuals who used or were exposed to Ozempic and suffered related injuries may qualify. Eligibility depends on usage duration, diagnosis, and state-specific deadlines.